West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET
Company Participants
John Sweeney – Vice President of Investor Relations
Eric Green – Chairman, President and Chief Executive Officer
Bernard Birkett – Senior Vice President and Chief Financial Officer
Conference Call Participants
Paul Knight – KeyBanc
Larry Solow – CJS Securities
Justin Bowers – Deutsche Bank
Michael Ryskin – Bank of America
David Windley – Jefferies
Daniel Markowitz – Evercore ISI
Thomas DeBourcy – Nephron Research
Doug Schenkel – Wolfe Research
Matt Etoch – Stephens
Patrick Donnelly – Citi
Matthew Larew – William Blair
Kyle Crews – UBS
Operator
Good day, and thank you for standing by. Welcome to the West Pharmaceutical Services First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, John Sweeney, Vice President of Investor Relations. Please go ahead.
John Sweeney
Good morning, and welcome to West’s first quarter 2025 earnings conference call.
We issued our financial results early this morning and the release has been posted in the Investors section of the Company’s website located at westpharma.com. On the call today, we will review our financial results, provide an update for our business and present our financial outlook for FY ’25. There’s a slide presentation that accompanies today’s call, and a copy of the presentation is available on the Investor page of West’s website.
On Slide 4, there’s a safe harbor statement and statements made by management on the call and in the accompanying presentation contain forward-looking statements from the meaning of the U.S. federal securities laws. These statements are based on
Read the full article here